A third case of monkeypox was confirmed in São Paulo this Tuesday (14). The patient is a 31-year-old man from São Paulo. He is hospitalized at the Instituto de Infectologia Emílio Ribas and has a good clinical picture and the case was confirmed through analysis by the Instituto Adolfo Lutz, according to the State Health Department.
The state of São Paulo had already confirmed two other cases. One of the patients was from the capital and another from the city of Vinhedo (85 km from SP). On Sunday (12), the Ministry of Health confirmed another case of a 51-year-old man who lives in Porto Alegre.
Like the other diagnoses, the new case confirmed in São Paulo is considered imported, due to the patient’s travel to European countries.
Worldwide, the WHO (World Health Organization) counts more than 1,000 confirmed cases in 29 countries. No deaths were recorded.
Monkeypox is caused by monkeypox, a virus of the genus orthopoxvirus. Another pathogen that is also of this genus is the one that causes smallpox, a disease eradicated in 1980.
Although they have their similarities, there are differences between the two diseases. One of them is lethality: smallpox killed about 30% of those infected. Monkeypox, on the other hand, has a mortality rate of between 3% and 6%, according to the WHO.
The most common symptoms appear within 6 to 13 days after exposure, but can take up to three weeks. People who get sick often have a fever, headache, back and muscle pain, swollen lymph nodes, and general exhaustion.
About one to three days after the fever, most people also develop a painful rash that is characteristic of this virus genus. The rash can start on the patient’s face, hands, feet, inside the mouth or on Organs genitals and progress to the rest of the body.
The disease was already known, but had been recorded mainly in African countries. What left the scientific community on alert was the rapid spread of the virus to other countries outside Africa.
To stop the spread, it is recommended the isolation of confirmed cases of the disease and application of the smallpox vaccine in the contacts that the patient had. The problem is that this immunizer is not available to the general public. In 2019, another vaccine was developed and demonstrated effectiveness in preventing monkeypox, but it has small-scale production.
Chad-98Weaver, a distinguished author at NewsBulletin247, excels in the craft of article writing. With a keen eye for detail and a penchant for storytelling, Chad delivers informative and engaging content that resonates with readers across various subjects. His contributions are a testament to his dedication and expertise in the field of journalism.
